International E-publication: Publish Projects, Dissertation, Theses, Books, Souvenir, Conference Proceeding with ISBN.  International E-Bulletin: Information/News regarding: Academics and Research

Computational studies of Some Phytochemicals against COVID 19 through Molecular Docking Approach

Author Affiliations

  • 1Dept. of Chemistry, Shri Vaishnav Vidyapeeth Vishwavidyalaya, Indore, MP, India
  • 2Devi Ahilya Vishwavidyalaya, Takshshila Campus, Khandwa Road, Indore, MP, India

Res.J.chem.sci., Volume 12, Issue (1), Pages 26-30, February,18 (2022)

Abstract

COVID-19is declared as a pandemic The World Health Organization declared COVID-19 as a pandemic on March12th 2020 and it’s very difficult to control this pandemic because there is no active vaccine or drug accessible for corona virus. Therefore, the objective of preset study is to analyze the inhibitory action of bioactive molecules from medicinal plants on 6W63 protein from protein data bank by computational docking studies and compare the result with recent reported inhibitory effect of chlorquine and hydroxyl chloroquine. It is well recognized that there is no available of efficient vaccine or drug for corona virus. We performed computational studies of phytochemicals versus Covid-19 main protease (PDB ID 6W63) with Molegro Virtual Docker 2013.6.0. (MVD). In our study active ingredients of Allicinof Allium sativum (Binding energy: -5.61 kcal/mole) shows better results than Chloroquine and Hydroxyl Chloroquine with minimum side effect. Based on binding energy score and ADMET studies of under examine compound, we compare the ADMET studies of reference compounds, and it is our suggestion that these compounds can be analyzed against corona virus and after that it can used to develop antivirus drug.

References

  1. Kumar, A., Choudhir, G., Shukla, S. K., Sharma, M., Tyagi, P., Bhushan, A., & Rathore, M. (2020)., Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches., Journal of Biomolecular Structure and Dynamics, 1-11. http://doi.org: 10.21203/rs.3.rs-31210/v1
  2. Joshi, T., Joshi, T., Sharma, P., Mathpal, S., Pundir, H., Bhatt, V., & Chandra, S. (2020)., In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking., Eur Rev Med Pharmacol Sci, 24(8), 4529-36.
  3. WHO (2020)., Coronavirus (COVID-19) Dashboard., http://www.who.int. Accessed 20 /8/ 2020.
  4. Chen, Y., Liu, Q., & Guo, D. (2020)., Emerging coronaviruses: genome structure, replication, and pathogenesis., Journal of medical virology, 92(4), 418-423.
  5. Pal, M., Berhanu, G., Desalegn, C., & Kandi, V. (2020)., Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an update., Cureus, 12(3). http://doi.org: 10.7759/ cureus.7423
  6. Zheng, J. (2020)., SARS-CoV-2: an emerging coronavirus that causes a global threat., International journal of biological sciences, 16(10), 1678. http:// doi.org: 10.7150/ ijbs.45053
  7. Fantini, J., Di Scala, C., Chahinian, H., & Yahi, N. (2020)., Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection., International journal of antimicrobial agents, 55(5), 105960. http:// doi.org:10.1016/j.ijantimicag.2020.105960
  8. Needle, D., Lountos, G. T., & Waugh, D. S. (2015)., Structures of the Middle East respiratory syndrome coronavirus 3C-like protease reveal insights into substrate specificity., Acta Crystallographica Section D: Biological Crystallography, 71(5), 1102-1111. http:// doi.org: 10.1107/S1399004715003521
  9. Tahir ul Qamar, M., Maryam, A., Muneer, I., Xing, F., Ashfaq, U. A., Khan, F. A., ... & Siddiqi, A. R. (2019)., Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus., Scientific reports, 9(1), 1-16.
  10. Srivastava, A. K., Kumar, A. & Misra, N. (2020)., On the Inhibition of COVID-19 Protease by Indian Herbal Plants: An In Silico Investigation., arXiv preprint arXiv:2004.034 11.
  11. RCSB (2013)., The RCSB Protein data bank., http://www.rcsb.org/structure/6W63 . Accessed 10/5/ 2020.
  12. Docker (2013)., The Molargo Virtual Docker (version 6.0)., [software] freeware available from: http://www.docker.com 2013.
  13. NCBI (2020)., The National Center for Biotechnology Information., www.ncbi.nim.nih.gov. Accessed 15/5/ 2020.
  14. Wadood, A., Ahmed, N., Shah, L., Ahmad, A., Hassan, H., & Shams, S. (2013)., In-silico drug design: An approach which revolutionarised the drug discovery process., OA Drug Des Deliv, 1(1), 3 http:// doi.org: 10.13172/2054-4057-1-1-1119
  15. Narkhede, R. R., Pise, A. V., Cheke, R. S., & Shinde, S. D. (2020)., Recognition of natural products as potential inhibitors of COVID-19 main protease (Mpro): In-silico evidences., Natural products and Bioprospecting, 10(5), 297-306. http:// doi.org: 10.1007/s13659-020-00253-1
  16. Chen, D., Oezguen, N., Urvil, P., Ferguson, C., Dann, S. M., & Savidge, T. C. (2016)., Regulation of protein-ligand binding affinity by hydrogen bond pairing., Science advances, 2(3), e1501240.http://doi.org: 10.1126/sciadv. 1501240
  17. Ben-Shabat, S., Yarmolinsky, L., Porat, D., & Dahan, A. (2020)., Antiviral effect of phytochemicals from medicinal plants: applications and drug delivery strategies., Drug Delivery and Translational Research, 10(2), 354-367.